HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.
about
Current perspectives in HIV post-exposure prophylaxis.Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013Nonoccupational post-exposure prophylaxis for HIV in New York State Emergency Departments.Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.Addressing the challenges of the HIV continuum of care in high-prevalence cities in the United States.Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEPNIH support of Centers for AIDS Research and Department of Health Collaborative Public Health Research: advancing CDC's Enhanced Comprehensive HIV Prevention Planning project.The effect of prevention methods on reducing sexual risk for HIV and their potential impact on a large-scale: a literature review.Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.Promotion of Research on the HIV Continuum of Care in the United States: The CFAR HIV Continuum of Care/ECHPP Working Group.HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami.Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County.2016 United Kingdom national guideline on the sexual health care of men who have sex with men.Suspected unexpected and other adverse reactions to antiretroviral drugs used as post-exposure prophylaxis of HIV infection - five-year experience from clinical practice.
P2860
Q34434815-77F7D7CF-05E8-455F-B5AC-EA99CC9DDA34Q34802731-18EA5081-1203-403B-A9EE-67B01971BF74Q35311656-A0801AC7-751B-4F3D-87D8-384B85331742Q35696557-C0B89912-F9EC-4CBB-8202-8236B148BF55Q35781306-353F1B4C-74BD-431C-A2CD-C755EE366177Q35838930-E0924132-7C4A-4BBC-87F0-FB37183E239EQ36278936-C1076EDC-6E68-45E0-A4D6-A9E81B902939Q37384124-ABC349BF-5E12-4369-866D-8A236748B1DAQ38656815-911DA689-61DD-4484-8407-4B52A5FF51C0Q38730568-8C8029B5-14ED-4966-8739-DA9FB5C4A628Q40384170-E4DA625F-1779-4A7E-B18B-A1830FA09F15Q40524587-75479046-9EEE-4C8A-A812-508FF58C5305Q46031583-04DE4DF4-9CA0-4ED1-B67E-D06C9DC6F670Q47553525-7A44E358-B52E-43F9-8748-E16958431A7AQ55025502-E9D82BEE-B9CB-479D-8053-1F223CFECA3F
P2860
HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
HIV medical providers' percept ...... in 2 major metropolitan areas.
@en
HIV medical providers' percept ...... in 2 major metropolitan areas.
@nl
type
label
HIV medical providers' percept ...... in 2 major metropolitan areas.
@en
HIV medical providers' percept ...... in 2 major metropolitan areas.
@nl
prefLabel
HIV medical providers' percept ...... in 2 major metropolitan areas.
@en
HIV medical providers' percept ...... in 2 major metropolitan areas.
@nl
P2093
P2860
P1476
HIV medical providers' percept ...... in 2 major metropolitan areas.
@en
P2093
Allan E Rodríguez
Amanda D Castel
Carrigan L Parish
Daniel J Feaster
Gabriel A Cardenas
Kira Villamizar
Liliana Vázquez-Rivera
Lisa R Metsch
Michael Kharfen
Michael Kolber
P2860
P304
P356
10.1097/QAI.0B013E3182A901A2
P407
P478
64 Suppl 1
P577
2013-11-01T00:00:00Z